<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of systemic low dose <z:chebi fb="0" ids="4031">cyclosporin-A</z:chebi> (5 mg/kg/day as initial dose) combined with 0.2 to 0.6 mg/kg/day <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (when necessary) in clinical course of 22 patients suffering from severe forms of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease are reviewed </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the patients had received other drugs previously and had either no response to them or developed intolerable side effects, therefore, pre treatment visual acuity (VA) was compared to post treatment VA as "self control" </plain></SENT>
<SENT sid="2" pm="."><plain>The average age of our patients was 30.6 years (range 19-51 years) </plain></SENT>
<SENT sid="3" pm="."><plain>The average duration of our therapy was 19.5 months (range 4-32 months) </plain></SENT>
<SENT sid="4" pm="."><plain>Improvement or stabilization of vision was achieved in 21 patients (95%) </plain></SENT>
<SENT sid="5" pm="."><plain>The intraocular <z:mp ids='MP_0001845'>inflammation</z:mp> was controlled in <z:hpo ids='HP_0000001'>all</z:hpo> of the eyes and most of the non-ocular signs and symptoms were also improved </plain></SENT>
<SENT sid="6" pm="."><plain>Serious side effects included rise in <z:chebi fb="0" ids="16737">creatinine</z:chebi> in 10 (45%) of the patients, rise in <z:chebi fb="0" ids="16990">bilirubin</z:chebi> in 6 (27%) and <z:hpo ids='HP_0000822'>hypertension</z:hpo> in 1 (4.5%) </plain></SENT>
<SENT sid="7" pm="."><plain>These side effects disappeared as the dose of <z:chebi fb="0" ids="4031">cyclosporin-A</z:chebi> was tapered </plain></SENT>
<SENT sid="8" pm="."><plain>We believe this form of therapy is of great value in the management of severe forms of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>